Prevention Of Cardiovascular Disease A Continuum An Issue Of Cardiology Clinics E Book

With the numerous advances that have been made in treatment of heart disease over the past 20 years, physicians are now emphasizing more than ever the prevention of heart disease. This issue provides cardiologists with practical state-of-the-art information on prevention that can be be easily applied to their patients. Topics covered include diabetes, lipid-lowering therapy, RAAS blockade, emerging therapies for atherosclerosis prevention, and heart disease in women.

In this issue of Primary Care: Clinics in Office Practice, guest editor Dr. Anthony Viera brings his considerable expertise to the topic of Cardiovascular Diseases. Top experts in the field discuss treatment and prevention of cardiovascular diseases in the post-COVID environment, including articles on lifestyle interventions for prevention of CVD; hypertension guidelines and interventions; acute coronary syndrome; heart failure; and more. Contains 13 relevant, practice-oriented topics including the burden of cardiovascular disease in the post-COVID era; novel therapies for hyperlipidemia; congenital heart disease; arrhythmias and sudden cardiac death; and more. Provides in-depth clinical reviews on cardiovascular diseases, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Despite remarkable therapeutic achievements in medicine, cardiovascular diseases remain the major cause of death in the new millennium. The cardiovascular disease continuum starts with risk factors such as hypertension, diabetes mellitus and lipid disorders, leading to coronary artery disease or left ventricular hypertrophy. Left ventricular dysfunction and remodelling follow after initial myocardial damage (e.g. myocardial infarction), finally leading to the development of heart failure. This book gives an overview of the effects of antiadrenergic treatment in the different stages of the cardiovascular continuum, with a particular emphasis on heart failure, authored by a faculty of leading international clinical cardiologists.

This issue of Cardiology Clinics will cover Nephrocardiology. Curated by Dr. Parta Hatamizadeh, this issue will explore topics in the field that are relevant for practicing clinicians. This issue is one of four selected each year by the series editorial board: Jamil A. Aboulhosn, David M. Shavelle, Terrence D. Welch, and Audrey H. Wu. The volume will include articles on: Uremic toxins and cardiovascular system, Anemia, a connection between heart failure and kidney failure, Pulmonary hypertension and chronic kidney disease, The impact of uric acid and hyperuricemia on cardiovascular and renal systems, Hemodialysis versus peritoneal dialysis in various cardiovascular disorders, Latest updates in cardiorenal syndrome and more.

In this issue, guest editors bring their considerable expertise to this important topic. Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.

This issue of Medical Clinics of North America provides the latest essential updates on coronary risk factors. The following key questions are answered. Are new biomarkers informative? LDL: the lower the better? How important is HDL? How much credit does triglyceride deserve? How important is family history of coronary disease? How important is age in determining coronary risk factors? Endothelial progenitor cells, menopause, and coronary risk factors? What is the role of imaging in prevention of coronary artery disease? Is genomics ready for primetime? Pediatric statinization? Individualized statinization? Polypill for some, polypill for all?

In this issue of Medical Clinics of North America, guest editors Drs. Alexander Fanaroff and John W. Hirschfeld, Jr., bring their considerable expertise to the topic of Patient Management with Stable Ischemic Heart Disease. Top experts provide insights into newer diagnostic modalities for patients presenting with symptoms of stable ischemic heart disease, review the pillars of medical management as well as emerging cardiometabolic therapies, provide updates on the role of revascularization, and reveal gender, racial, ethnic, and socioeconomic disparities in the presentation and management of stable ischemic heart disease. Contains 13 relevant, practice-oriented topics including optimal medical therapy for stable ischemic heart disease in 2024: focus on antithrombotic therapy; antiplatelet therapy for patients that have undergone revascularization within the past year: which agents and for how long; ischemic heart disease in women: focus on SCAD and MINOCA; and more. Provides in-depth clinical reviews on patient management with stable ischemic heart disease, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

PREVENTIVE CARDIOLOGY is the premier source of clinically relevant information on the prevention of coronary heart disease. Thoroughly updated by international experts, the book discusses screening, risk factors, prevention in special populations, and primary and secondary prevention in the context of the daily practice of medicine. PREVENTIVE CARDIOLOGY is a "must have" for cardiologists and primary care physicians. Review of the first edition: "Excellent...Structured in a way that invites the reader to use it as a comprehensive reference...The combination of theory and guidelines with a practical approach to the patient at risk for cardiovascular diseases is a strength." The New England Journal of Medicine